BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 905969)

  • 21. Progress in the measurement of circulating fibrinogen derivatives.
    Wilner GD
    Prog Clin Pathol; 1984; 9():15-45. PubMed ID: 6229812
    [No Abstract]   [Full Text] [Related]  

  • 22. Fibrinopeptide A (FPA) radioimmunoassay influence of the affinity of the second antibody for FPA antiserum.
    Harenberg J; Stehle G; Schmidt-Gayk H; Zimmermann R
    Thromb Res; 1981 Feb 15-Mar 1; 21(4-5):531-2. PubMed ID: 7268698
    [No Abstract]   [Full Text] [Related]  

  • 23. Fibrinogen Petoskey: identification of a new dysfibrinogenemia characterized by altered release of fibrinopeptide A.
    Higgins DL; Penner JA; Shafer JA
    Thromb Res; 1981 Sep; 23(6):491-504. PubMed ID: 6459662
    [No Abstract]   [Full Text] [Related]  

  • 24. Measurement of fibrinopeptide A in canine blood-an interim report.
    Wilner GD
    Thromb Res; 1979; 15(5-6):601-10. PubMed ID: 494165
    [No Abstract]   [Full Text] [Related]  

  • 25. Fibrinogen survival and fibrinopeptide A in acute leukemia.
    Castaman G; Galloni E; Dri AV; Rodeghiero F
    Haematologica; 1993; 78(6 Suppl 2):52-6. PubMed ID: 8039760
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fibrinogen Aarhus--a new case of dysfibrinogenemia.
    Hessel B; Stenbjerg S; Dyr J; Kudryk B; Therkildsen L; Blombäck B
    Thromb Res; 1986 Apr; 42(1):21-37. PubMed ID: 2939591
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fibrin detected in plasma of patients with disseminated intravascular coagulation by fibrin-specific antibodies consists primarily of high molecular weight factor XIIIa-crosslinked and plasmin-modified complexes partially containing fibrinopeptide A.
    Pfitzner SA; Dempfle CE; Matsuda M; Heene DL
    Thromb Haemost; 1997 Sep; 78(3):1069-78. PubMed ID: 9308756
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Guide wire thrombogenicity measured by fibrinopeptide A radioimmunoassay.
    Casarella WJ; Wilner GD
    AJR Am J Roentgenol; 1977 Mar; 128(3):363-6. PubMed ID: 402829
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of a commercial kit for the radioimmunoassay of fibrinopeptide A.
    Butt RW; deBoer AC; Turpie AG
    J Immunoassay; 1984; 5(3-4):245-66. PubMed ID: 6530485
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radioimmunoassay for measurement of fibrinogen.
    Mohamed FA; Barnhart MI
    New Istanbul Contrib Clin Sci; 1976 Dec; 11(3):119-26. PubMed ID: 1028026
    [No Abstract]   [Full Text] [Related]  

  • 31. Immunoassay of human fibrinopeptides.
    Butler VP; Nossel HL; Canfield RE
    Methods Enzymol; 1982; 84():102-18. PubMed ID: 7048006
    [No Abstract]   [Full Text] [Related]  

  • 32. [Studies on early plasmin degradation product "fragment A" of human fibrinogen - isolation, characterization, radioimmunoassay for fragment A and its clinical significance (author's transl)].
    Takagi K
    Nihon Naika Gakkai Zasshi; 1977 Jun; 66(6):621-32. PubMed ID: 915359
    [No Abstract]   [Full Text] [Related]  

  • 33. Elevated plasma levels of fibrinopeptide A during sickle cell anemia pain crisis--evidence for intravascular coagulation.
    Leichtman DA; Brewer GJ
    Am J Hematol; 1978; 5(3):183-90. PubMed ID: 752258
    [No Abstract]   [Full Text] [Related]  

  • 34. Intraperitoneal heparin in peritoneal dialysis and its effect on fibrinopeptide A in plasma and dialysate.
    Gries E; Paar D; Graben N; Bock KD
    Haemostasis; 1989; 19(1):21-5. PubMed ID: 2920976
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heparin dosing and monitoring for cardiopulmonary bypass. A comparison of techniques with measurement of subclinical plasma coagulation.
    Gravlee GP; Haddon WS; Rothberger HK; Mills SA; Rogers AT; Bean VE; Buss DH; Prough DS; Cordell AR
    J Thorac Cardiovasc Surg; 1990 Mar; 99(3):518-27. PubMed ID: 2308370
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fibrinopeptide A in urine from patients with venous thromboembolism, disseminated intravascular coagulation and rheumatoid arthritis--evidence for dephosphorylation and carboxyterminal degradation of the peptide by the kidney.
    Leeksma OC; Meijer-Huizinga F; Stoepman-van Dalen EA; van Aken WG; van Mourik JA
    Thromb Haemost; 1985 Dec; 54(4):792-8. PubMed ID: 4089813
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fibrinogen derivatives in plasma.
    Lane DA
    Br J Haematol; 1981 Mar; 47(3):329-35. PubMed ID: 6161635
    [No Abstract]   [Full Text] [Related]  

  • 38. [Approach of hematology. Abnormal findings of coagulation and fibrinolytic factors in DIC].
    Ikematsu S; Kato M; Kuroso K
    Rinsho Byori; 1984 Aug; 32(8):862-8. PubMed ID: 6502985
    [No Abstract]   [Full Text] [Related]  

  • 39. The utility of plasma fibrinopeptide assays.
    Owen J
    Thromb Haemost; 1989 Sep; 62(2):807-10. PubMed ID: 2814929
    [No Abstract]   [Full Text] [Related]  

  • 40. Intraperitoneal fibrin-formation and its inhibition in CAPD.
    Gries E; Paar D; Graben N; Bock KD
    Clin Nephrol; 1986 Oct; 26(4):209-12. PubMed ID: 3780071
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.